ASPG and acute lymphoblastic leukemia: This study aimed to analyze the toxicity profile associated with the administration of native E. coli-derived L-asparaginase during the first-line chemotherapy protocol used in children and adolescents diagnosed with acute lymphoblastic leukemia and to compare the overall survival (OS) and event-free survival (EFS) of patients who showed toxicity vs. patients without toxicity.